AltruBio Competitors and Similar CompaniesClear all

AltruBio's competitors and similar companies include Biocon, Takeda Oncology, Kyowa Kirin and 3sbio.
AltruBio
AltruBio
AltruBio (formerly AbGenomics) is a biopharmaceutical company focused on developing antibody therapeutics for the treatment of cancer and immune-related inflammatory diseases.
Biocon
Biocon
Biocon is a company that develops and manufactures biopharmaceutical products.
Takeda Oncology
Takeda Oncology
Takeda Oncology is a biopharmaceutical company developing medicines for the treatment of oncology and inflammation diseases.
Kyowa Kirin
Kyowa Kirin
Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system.
3sbio
3sbio
3sbio (三生制药集团) is a company that develops biopharmaceuticals.
Founding Date
Founding Date
2006
Founding Date
1978
Founding Date
1993
Founding Date
2008
Founding Date
1993
Type
Type
Private
Type
Public
Type
Subsidiary
Type
Public
Type
Public
Tags
Locations
Locations
Redwood City, US HQ
Amsterdam, NL
Locations
Bengaluru, IN HQ
Bengaluru, IN
Nanakramguda, IN
Dublin, IE
Kuala Lumpur, MY
Puchong, MY
Delémont, CH
see more
Locations
Cambridge, US HQ
Locations
Tokyo, JP HQ
Sydney, AU
Shanghai, CN
Prague, CZ
Tampere, FI
Düsseldorf, DE
Hong Kong, HK
see more
Locations
Shenyang, CN HQ
Employees
Employees
296% decrease
Employees
16,5612% increase
Employees
1,6441% decrease
Employees
5,669
Employees
5,577

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
₹167.8b (FY, 2026)
Revenue (est.)
N/A
Revenue (est.)
¥496.8b (FY, 2025)
Revenue (est.)
¥17.7b (FY, 2025)
Cost of goods
Cost of goods
N/A
Cost of goods
₹56.9b (FY, 2026)
Cost of goods
N/A
Cost of goods
¥114.3b (FY, 2025)
Cost of goods
¥818m (FY, 2025)
Gross profit
Gross profit
N/A
Gross profit
₹115.8b (FY, 2026)
Gross profit
N/A
Gross profit
¥383.4b (FY, 2025)
Gross profit
¥17b (FY, 2025)
Net income
Net income
N/A
Net income
₹3.7b (FY, 2026)
Net income
N/A
Net income
¥67b (FY, 2025)
Net income
¥9.1b (FY, 2025)

Funding

Total funding raised
Total funding raised
$ 39.7m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 15.2m
For sources of this data, please see the company profile

View Company Profiles

Biocon
HQ
Bengaluru, IN
Employees
16,561↑ 2% increase

Biocon is a company that develops and manufactures biopharmaceutical products.

View company
Takeda Oncology
HQ
Cambridge, US

Takeda Oncology is a biopharmaceutical company developing medicines for the treatment of oncology and inflammation diseases.

View company
Kyowa Kirin
HQ
Tokyo, JP
Employees
5,669

Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system.

View company
3sbio
HQ
Shenyang, CN
Employees
5,577

3sbio (三生制药集团) is a company that develops biopharmaceuticals.

View company